Phase I Study of Erlotinib Plus Radiation Therapy in Patients with Advanced Cutaneous Squamous Cell Carcinoma

PURPOSE: Recurrent or advanced stage cutaneous squamous cell carcinoma (cSCC) is difficult to treat and available therapies have a high failure rate. Anti-epidermal growth factor receptor therapy (EGFR) is associated with a facial rash that may potentiate radiation related cutaneous toxicities. The...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Heath, C. Hope, Deep, Nicholas L, Nabell, Lisle, Carroll, William R, Desmond, Renee, Clemons, Lisa, Spencer, Sharon, Magnuson, J. Scott, Rosenthal, Eben L
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607201/
https://ncbi.nlm.nih.gov/pubmed/23182701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2012.09.030
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares